NewAmsterdam Pharma Co N.V. (NAMS, NAMSW)

CIK 1936258 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NewAmsterdam Pharma Co N.V..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002799
Nov 4, 202610-Q0001193125-26-446228
Nov 4, 20268-K0001193125-26-446219
Oct 2, 202640001193125-26-412431
Sep 29, 20268-K0001193125-26-406063
Sep 22, 2026SCHEDULE 13D/A0001231919-26-001215
Sep 21, 20268-K0001193125-26-396716
Sep 15, 202640001193125-26-391985
Sep 9, 202640001193125-26-386508
Sep 3, 202640001193125-26-381953
Aug 25, 2026144/A0001968582-26-000878
Aug 25, 202640001193125-26-365202
Aug 24, 20261440001968582-26-000868
Aug 14, 202630001193125-26-352209
Aug 14, 20268-K0001193125-26-352186
Aug 14, 20268-K/A0001193125-26-352233
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002082
Aug 5, 202610-Q0001193125-26-333824
Aug 5, 20268-K0001193125-26-333827
Jul 24, 20268-K0001193125-26-315163
Jul 22, 202640001193125-26-312387
Jul 22, 20268-K0001193125-26-312390
Jun 24, 202640001193125-26-281062
Jun 5, 2026S-80001193125-26-259794
Jun 4, 2026SCHEDULE 13G/A0001422849-26-000108